Duygu Agagündüz1
Ermelinda Cocozza2Özge Cemali1Ayşe Derya Bayazıt1Maria Francesca Nanì3
Ida Cerqua3
Floriana Morgillo4
Suna Karadeniz Saygılı5,6
Roberto Berni Canani7
Paola Amero5*
Raffaele Capasso8*- 1Department of Nutrition and Dietetics, Gazi University, Emek, Ankara, Türkiye
- 2MERCK S.P.A., Rome, Italy
- 3Department of Pharmacy, University of Naples “Federico II”, Naples, Italy
- 4Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania “Luigi Vanvitelli”, Naples, Italy
- 5Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- 6Department of Histology and Embryology, Kütahya Health Sciences University, Kütahya, Türkiye
- 7Department of Translational Medical Science and ImmunoNutritionLab at CEINGE Biotechnologies Research Center and Task Force for Microbiome Studies, University of Naples Federico II, Naples, Italy
- 8Department of Agricultural Sciences, University of Naples Federico II, Portici, Italy
A Correction on
Understanding the role of the gut microbiome in gastrointestinal cancer: A review
by Ağagündüz D, Cocozza E, Cemali Ö, Bayazıt AD, Nanì MF, Cerqua I, Morgillo F, Saygılı SK, Berni Canani R, Amero P and Capasso R (2023). Front. Pharmacol. 14:1130562. doi: 10.3389/fphar.2023.1130562
In the published article, an incorrect Funding statement was provided. The corrected Funding statement appears below.
The original article has been updated.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. The paper was funded under the National Recovery and Resilience Plan (NRRP), Mission 4 Component 2 Investment 1.3—Call for tender No. 341 of 15 March 2022 of Italian Ministry of University and Research funded by the European Union—NextGenerationEU. Project code PE00000003, Concession Decree No. 1550 of 11 October 2022, adopted by the Italian Ministry of University and Research, CUP E63C22002030007, Project title “ON Foods—Research and innovation network on food and nutrition Sustainability, Safety and Security—Working ON Foods.”
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: microbiome, gastrointestinal cancer, non-coding RNAs, therapeutics, diagnosis
Citation: Agagündüz D, Cocozza E, Cemali Ö, Bayazıt AD, Nanì MF, Cerqua I, Morgillo F, Saygılı SK, Canani RB, Amero P and Capasso R (2025) Correction: Understanding the role of the gut microbiome in gastrointestinal cancer: A review. Front. Pharmacol. 16:1662597. doi: 10.3389/fphar.2025.1662597
Received: 09 July 2025; Accepted: 17 July 2025;
Published: 30 July 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Agagündüz, Cocozza, Cemali, Bayazıt, Nanì, Cerqua, Morgillo, Saygılı, Canani, Amero and Capasso. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Raffaele Capasso, cmFmY2FwYXNAdW5pbmEuaXQ=; Paola Amero, UEFtZXJvQG1kYW5kZXJzb24ub3Jn